Linked Life Data

16204016

Source:http://linkedlifedata.com/resource/pubmed/id/16204016

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
31
pubmed:dateCreated
2005-10-31
pubmed:abstractText
To study efficacy and safety of re-treatment with I-131 tositumomab in patients with low-grade, follicular, or transformed low-grade B-cell lymphoma who relapsed following a response to I-131 tositumomab.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7985-93
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16204016-Adult, pubmed-meshheading:16204016-Aged, pubmed-meshheading:16204016-Antibodies, Monoclonal, pubmed-meshheading:16204016-Antigens, CD20, pubmed-meshheading:16204016-Antineoplastic Agents, pubmed-meshheading:16204016-Female, pubmed-meshheading:16204016-Humans, pubmed-meshheading:16204016-Immunoconjugates, pubmed-meshheading:16204016-Iodine Radioisotopes, pubmed-meshheading:16204016-Lymphoma, B-Cell, pubmed-meshheading:16204016-Lymphoma, Follicular, pubmed-meshheading:16204016-Lymphoma, Non-Hodgkin, pubmed-meshheading:16204016-Male, pubmed-meshheading:16204016-Middle Aged, pubmed-meshheading:16204016-Neoplasm Recurrence, Local, pubmed-meshheading:16204016-Radioimmunotherapy, pubmed-meshheading:16204016-Retreatment, pubmed-meshheading:16204016-Survival Rate, pubmed-meshheading:16204016-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomab.
pubmed:affiliation
University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. mkaminsk@umich.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II